Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.23.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Stock Option Awards
Following is a summary of stock option activities for the three months ended March 31, 2023:
Options Weighted
Average
Exercise Price
Weighted
Average
Grant Date
Fair Value
Weighted
Average
Remaining
Life
(years)
Intrinsic
Value
Outstanding – January 1, 2023 7,603,864  $ 0.19  $ 0.21  4.6 $ 25,795 
Granted —  —  — 
Exercised (300,785) 0.18  0.24 
Forfeited —  —  — 
Outstanding – March 31, 2023
7,303,079  $ 0.19  $ 0.21  4.3 $ 23,312 
Exercisable as of March 31, 2023
7,303,079  $ 0.19  $ 0.21  4.3 $ 23,312 
For the three months ended March 31, 2023 and 2022, the Company recorded no stock option expense. As of March 31, 2023, there are no remaining stock options subject to amortization.
Restricted Stock
During the three months ended March 31, 2023, the Company granted an aggregate of 177,389 of the Company's restricted stock units to various employees, officers, directors, consultants, and service providers under the 2021 Equity Incentive Plan. The restricted stock units have various vesting dates, ranging from vesting on the grant date to as late as four years from the date of grant.

Restricted Stock Units
Weighted Average Grant Date
Fair Value
Non-vested – January 1, 2023 7,466,636  $ 5.52 
Granted
177,389  3.26 
Vested
(160,237) 8.09 
Forfeited
(24,751) 6.49 
Non-vested – March 31, 2023
7,459,037  $ 5.41 
For the three months ended March 31, 2023 and 2022, the Company recorded $3,221 and $2,098 in employee and officers restricted stock compensation expense. As of March 31, 2023, unamortized stock-based compensation costs related to restricted share arrangements was $32,285 and will be recognized over a weighted average period of 3.3 years.
Stock-Based Compensation Expense
Stock-based compensation expense for stock options and restricted stock units in the unaudited interim condensed consolidated statements of operations is summarized as follows:
Three Months Ended
March 31,
2023 2022
Software development
$ 168  $ 275 
General and administrative(1)
2,636  1,723 
Selling and marketing
78  100
Total stock-based compensation expense
$ 2,882  $ 2,098 
________
(1) For the three months ended March 31, 2023, the Company includes a credit of $339 in connection with the settlement of the equity-based portion of Trinity’s contingent consideration that was paid in 2023 in respect of 2022 results.